Results 101 to 110 of about 34,440,044 (184)

Glucagon-Like Peptide-1 Receptor Agonists in Cocaine Use Disorder: Clinical Observations and Underlying Mechanisms. [PDF]

Fundam Clin Pharmacol
Eiden C, Chautard G, Batisse A, Aquizerate A, Luquiens A, Donnadieu H, Faillie JL, Peyriere H.   +7 more
europepmc   +1 more source

Impurities and Potential Immunogenicity Associated With Follow-on and Compounded Glucagon-like Peptide-1 Receptor Agonists. [PDF]

Pharm Res
Kopp KL, Lamberth K, Schelde O, Øgendahl AK, Wojcieszek M, Mogensen JE, Ramírez-Andersen HS, Schneider CL, Staby A, Hach M.   +9 more
europepmc   +1 more source

Novel Compounds as Glucagon-Like Peptide‑1 Receptor Agonists for Treating Diabetes. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source

Association Between Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review. [PDF]

Diabetes Obes Metab
Chan TH, Cosler LE, Gionfriddo MR, Leppien EE, Sommers EJ, Lussier ME.   +5 more
europepmc   +1 more source

Use of Glucagon-Like Peptide-1 Receptor Agonists in Danish Adolescents and Young Adults 2018-2025. [PDF]

Obesity (Silver Spring)
Kildegaard H, Andersen JH, Vinding RK, Kloppenborg JT, Pottegård A.   +4 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists and rotator cuff disease: a scoping review. [PDF]

BMC Musculoskelet Disord
Duru DO, Zhou AK, Lee DKR, Carroll PJ, Elmaraghy A.   +4 more
europepmc   +1 more source

Metabolic Modulation in Cancer Care: The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists. [PDF]

J Clin Oncol
Temperley HC, Kelly ME.
europepmc   +1 more source

Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes. [PDF]

Dermatol Ther (Heidelb)
Piraccini BM, Vañó-Galván S, Blume-Peytavi U, Ribet V, Mengeaud V.   +4 more
europepmc   +1 more source

State‐Level Variation in Glucagon‐Like Peptide‐1 Receptor Agonists Fills and Spending by Obesity Prevalence, 2023

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Tamkeen Khan, Stavros Tsipas, Fleetwood Loustalot, Lindsay Zasadzinski, Klodiana Myftari, Alyson B. Goodman, Gregory D. Wozniak   +6 more
doaj   +1 more source

Efficacy and safety of glucagon-like peptide-1 receptor agonists for diabetic cardiomyopathy: a protocol for systematic review and meta-analysis. [PDF]

BMJ Open
Tang B, Yu Y, Tang Y, Yu R, Liu X.
europepmc   +1 more source